[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100497250":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":37,"locations":43,"responsibleParty":60,"collaborators":31,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":31,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":31,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":31,"overallStatus":46,"whyStopped":31,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active treatment (Yunzhi Essence)","EXPERIMENTAL","Subjects will take 2 Yunzhi capsules, 4 times daily, for 6 months.",[13],"Drug: Yunzhi Essence",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Subjects will take 2 placebo capsules, 4 times daily, for 6 months",[19],"Other: Placebo",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Yunzhi Essence","Yunzhi Essence capsule",[9],[27],"Yunzhi",{"type":6,"name":15,"description":29,"armGroupLabels":30,"otherNames":31},"Placebo capsules",[15],null,[33],{"name":34,"affiliation":35,"role":36},"Zhixiu Lin","Hong Kong Institute of Integrative Medicine","PRINCIPAL_INVESTIGATOR",[38],{"name":39,"role":40,"phone":41,"phoneExt":31,"email":42},"Cho Wing Lo","CONTACT","35053476","louislo@cuhk.edu.hk",[44],{"facility":45,"status":46,"city":47,"state":31,"zip":31,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"School of Chinese Medicine","RECRUITING","Hong Kong","HK",{"type":50,"coordinates":51},"Point",[52,53],114.17469,22.27832,{"lat":53,"lon":52},[56],{"name":57,"role":40,"phone":58,"phoneExt":31,"email":59},"Prof. Lin","852-28733252","linzx@cuhk.edu.hk",{"type":36,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Prof. Lin Zhixiu","Professor","100497250","phase-2-yunzhi-essence-to-improve-the-quality-of-life-of-patients-with-advanced-stage-of-cancer-100497250",false,"NCT05754801","Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer","Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer: A Randomized, Double-blinded, Placebo-controlled Trial","Inclusion Criteria:\n\n* Diagnosed with advanced cancer according to the definition from American Cancer Society;\n* According to the experience of the doctor, by using Palliative Prognostic Index (score\\>4), integrated with past cases and professional knowledge judged to have life expectancy not less than six months to two years;\n* Abbreviated mental test (AMT) score of 6 or above;\n* Voluntarily participate in this clinical trial and sign the informed consent form (acceptance of close relatives signed informed consent on behalf of the patient);\n* Refer to the national standard for Clinic terminology of traditional Chinese medical diagnosis and treatment-Part 2:Syndromes\u002Fpatterns, syndrome of \"damp heat spleen\" and \"spleen deficiency with water stop\" (Fulfill 2 of the main symptoms and 2 of the secondary symptoms).\n\nExclusion Criteria:\n\n* Patients with a history of allergy to traditional Chinese medicine or Yunzhi;\n* Patients who required nasal feeding or difficulty swallowing;\n* Patients with comatose\u002Fsemi-conscious, cognitively impaired with dementia\u002Fconfusion, physically too ill with extremely poor general condition, or there was a language barrier.","ALL","21 Years","89 Years",{"count":74,"type":75},172,"ESTIMATED","INTERVENTIONAL",[78],"PHASE2","A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine 'Coriolus Versicolor for improving the quality of life of patients with advanced-stage cancer. Subjects will be randomized into a treatment group or placebo group for 6 months.",[81,82],"Cancer","Palliative Care","2026-07-28",{"date":85,"type":86},"2026-07-30","ACTUAL",{"date":88,"type":86},"2024-01-05",{"date":90,"type":75},"2027-09-30",{"name":5,"class":6},1]